Clinical trials
COPD clinical trials
Chronic obstructive pulmonary disease, a group of lung conditions that block airflow. We’re tracking 415 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06563544Recruiting
Two ventilator settings for asthma and COPD patients
This study compares two different ways of delivering breaths from a ventilator for people with severe asthma or COPD. The goal is to see which method might be better for your lungs.
Rotterdam, South HollandAges 18–100 - NCT04136717Recruiting
Test if FreeO2 helps keep oxygen levels in range
This study looks at whether adding FreeO2 can help keep your oxygen saturation (a measure of oxygen in the blood) within a target range while you use breathing support like NIV or CPAP. It may help reduce time spent either too low or too high in oxygen levels.
Québec, QuebecAges 18 years+ - NCT06531798RecruitingPhase 4
Safety study of Breztri aerosphere in Indian COPD patients
This study tests a medication called Breztri aerosphere (a triple-combination inhaler) to see how safe and well-tolerated it is in Indian patients with COPD who have had recent flare-ups. It may help people who need better control of their breathing symptoms.
BangaloreAges 18 years+ - NCT06512064Recruiting
Breath sound analysis for lung health
This study tests a new device that listens to your breathing to check how well your lungs are working. It might help diagnose lung conditions without the need for forceful blowing tests, making it easier for patients.
Indianapolis, IndianaAges 8–70 - NCT06505603Recruiting
PiMZ alpha-1 deficiency progression study
This study is looking at people with a specific mild form of alpha-1 antitrypsin deficiency (PiMZ) to understand how their lung disease progresses over time. It involves lung function tests and CT scans, and may help researchers learn more about the condition.
Birmingham, AlabamaAges 18 years+ - NCT06419062Enrolling by invitation
Using wearables to monitor COPD at home
This study tests if a wearable device can help track your COPD symptoms between doctor visits. You'll use a smartphone or computer to share data, which may help your care team stay on top of your health.
GlasgowAges 18 years+ - NCT06419036Enrolling by invitation
Using medical devices to monitor COPD at home
This study tests whether wearable medical devices can help monitor your COPD symptoms at home. You will use a smartphone app and a small chest patch to track your breathing, which may help you and your doctor better manage your condition.
GlasgowAges 18 years+ - NCT06390345Recruiting
Telehealth lifestyle and exercise for COPD and sleep apnea
This study tests a telehealth program that combines lifestyle coaching and exercise to help people with both COPD and sleep apnea improve their breathing and daily function. It may be a good fit if you are overweight, have a history of smoking, and feel short of breath during light activity.
Boise, IdahoAges 18 years+ - NCT06377410Recruiting
Ivy extract vs NAC for COPD: Which works better?
This study compares two treatments – a dry powder ivy extract and a common mucus-thinning medicine called NAC – to see which is safer and more effective for people with stable COPD. If you have COPD and are over 40, this trial could help find a better option to manage your symptoms.
Cheras, Kuala LumpurAges 40 years+ - NCT06366113Recruiting
Morning vs. afternoon exercise for COPD rehab
This study tests whether the time of day you exercise (morning vs. afternoon) affects how much you improve during a COPD rehabilitation program. It may help you get the most benefit from your rehab sessions.
LilleAges 18–85 - NCT06332885Recruiting
Zephyr Valve study for severe COPD patients in Japan
This study is tracking the real-world use of the Zephyr Valve, a device that helps people with severe COPD breathe easier. It will check if the valve is safe and works well for people in Japan who have been chosen for this treatment by their doctor.
AichiAges 18 years+ - NCT06334575RecruitingPhase 4
COPD treatment study based on eosinophil levels
This trial tests if inhaled corticosteroids (ICS) work better for COPD patients with different eosinophil levels. You must already be taking two long-acting bronchodilators and have stopped smoking for at least 6 months.
MarburgAges 40 years+ - NCT06283966RecruitingPhase 3
Triple inhaler for COPD with heart risk
This study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) to see if it can help protect the heart and lungs in people with COPD who also have heart problems or high risk for them.
Athens, AlabamaAges 40–80 - NCT06253013Recruiting
CHARM-COPD program of care after a flare-up
This study tests a program of care called CHARM-COPD for people who recently left the hospital after a COPD flare-up. It offers virtual pulmonary rehab or remote monitoring to help you recover and manage your condition at home.
Toronto, OntarioAges 40 years+ - NCT06236347Enrolling by invitation
Rural COPD study using e-visits for smokers
This study tests whether online e-visits can help rural smokers without COPD quit smoking. It uses smartphone tools and mailed devices to track progress remotely.
Charleston, South CarolinaAges 40 years+ - NCT06188065Recruiting
Eosinopenia and Recovery in Severe COPD Exacerbation
This study is looking at people admitted to the hospital for a severe COPD flare-up. It checks if a low level of eosinophils (a type of white blood cell) in the blood is linked to how quickly you recover from the flare-up.
North ShieldsAges 35 years+ - NCT06181357Recruiting
Comparing one-step vs. two-step valve placement for severe emphysema
This trial tests whether placing ZEPHYR® valves in two stages reduces the risk of a collapsed lung (pneumothorax) compared to the usual one-stage procedure. It is for people with severe emphysema who have already quit smoking and meet specific lung function criteria.
BordeauxAges 35–80 - NCT06144476Recruiting
Lung inflammation study in healthy and diseased lungs
This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.
London, LondonAges 18 years+ - NCT06110403RecruitingPhase 1/Phase 2
Study of a long-acting inhaler for COPD symptoms and lung function
This trial tests a once-daily inhaler that combines a long-acting bronchodilator with a corticosteroid to see if it improves breathing, lung function, and quality of life in people with moderate-to-severe COPD who have significant shortness of breath.
LilleAges 40–75 - NCT01177618Recruiting
Study of early-onset severe COPD in younger adults
This study looks at people who develop COPD (a long-term lung breathing problem) at a younger age and have severe airflow limitation. It may help researchers better understand COPD in early-onset patients and find ways to improve care for this group.
Boston, MassachusettsAges Any age - NCT06068647Recruiting
Ultrasound and breathing tests for lung disease patients
This study uses ultrasound and sensors to monitor lung health in people with certain lung conditions, including those that cause scarring or breathing problems. It aims to find better ways to track lung disease, which could help manage your condition more effectively.
RomeAges 18 years+ - NCT01776398Recruiting
Donating breath, blood, and urine samples for lung research
This study collects airway samples (usually during a bronchoscopy), plus blood and/or urine, to help researchers study lung conditions. It may help advance understanding of lung disease and related biology, but it is not a treatment trial.
New York, New YorkAges 18 years+ - NCT06035120Recruiting
Sealing damaged lung parts in severe emphysema
This trial tests a new treatment called AeriSeal to seal off damaged parts of the lung in people with severe emphysema. It aims to help you breathe better by reducing the amount of air trapped in your lungs.
Phoenix, ArizonaAges 40–80 - NCT05785026Recruiting
Menthol to reduce breathlessness in COPD and healthy adults
This trial tests whether menthol helps with breathlessness (dyspnea) during exercise. You may be asked to do breathing and exercise tests, and to use menthol under study supervision to see if symptoms improve.
LeuvenAges 18 years+
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for copd?
- Yes. Clin2 currently lists 415 recruiting copd studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a copd trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a copd trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.